Search

Solution structure of human insulin at pH 1.9
Authors
Hexnerova, R., Krizkova, K., Maletinska, L., Jiracek, J., Brzozowski, A.M., Zakova, L., Veverka, V.
Assembly
human insulin
Entity
1. human insulin, entity 1 (polymer, Thiol state: all disulfide bound), 21 monomers, 2383.696 Da Detail

GIVEQCCTSI CSLYQLENYC N


2. human insulin, entity 2 (polymer, Thiol state: all disulfide bound), 30 monomers, 3429.919 Da Detail

FVNQHLCGSH LVEALYLVCG ERGFFYTPKT


Total weight
5813.615 Da
Max. entity weight
3429.919 Da
Entity Connection
disulfide 3 Detail

IDTypeValue orderAtom ID 1Atom ID 2
1disulfidesing1:CYS6:SG1:CYS11:SG
2disulfidesing1:CYS7:SG2:CYS7:SG
3disulfidesing1:CYS20:SG2:CYS19:SG

Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
torsion angle dynamics, molecular dynamics
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 100.0 %, Completeness: 79.7 %, Completeness (bb): 75.7 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All79.7 % (471 of 591)98.0 % (296 of 302)57.1 % (133 of 233)75.0 % (42 of 56)
Backbone75.7 % (230 of 304)97.1 % (102 of 105)61.7 % (92 of 149)72.0 % (36 of 50)
Sidechain85.3 % (285 of 334)98.5 % (194 of 197)64.9 % (85 of 131)100.0 % (6 of 6)
Aromatic48.6 % (34 of 70)97.1 % (34 of 35) 0.0 % (0 of 35)
Methyl87.5 % (49 of 56)100.0 % (28 of 28)75.0 % (21 of 28)

1. entity 1

GIVEQCCTSI CSLYQLENYC N

2. entity 2

FVNQHLCGSH LVEALYLVCG ERGFFYTPKT

Sample

Solvent system 95% H2O/5% D2O, Pressure 1 atm, Temperature 298 K, pH 1.9


#NameIsotope labelingTypeConcentration
1entity_1natural abundance4 mM
2entity_2natural abundance4 mM
3acetic acid[U-99% 2H]20 %
4H2Onatural abundance95 %
5D2O[U-99% 2H]5 %

Protein Blocks Logo
Calculated from 50 models in PDB: 2MVC, Strand ID: A, B Detail


Release date
2016-09-12
Citation
Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young
Krizkova, K., Veverka, V., Maletinska, L., Hexnerova, R., Brzozowski, A., Jiracek, J.M., Zakova, L.
PLoS One (2014), 9, e112883-e112883, PubMed 25423173 , DOI 10.1371/journal.pone.0112883 ,
Related entities 1. human insulin, entity 1, : 1 : 111 : 13 : 7 : 90 entities Detail
Related entities 2. human insulin, entity 2, : 1 : 109 : 4 : 18 : 86 entities Detail
Interaction partners 1. human insulin, entity 1, : 1 : 1 interactors Detail
Interaction partners 2. human insulin, entity 2, : 6 : 1 interactors Detail
Experiments performed 4 experiments Detail
NMR combined restraints 4 contents Detail
Keywords insulin